Challenges in imaging assessment following liver stereotactic body radiotherapy: Pitfalls to avoid in clinical practice

Connie Yip*, Gary J.R. Cook, Kasia Owczarczyk, Vicky Goh

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

10 Citations (Scopus)
320 Downloads (Pure)

Abstract

Stereotactic body radiotherapy (SBRT) is increasingly used in the management of unresectable liver metastases and hepatocellular carcinoma (HCC) as it allows delivery of high-dose conformal radiotherapy with limited toxicities. However, it may be difficult to differentiate viable tumour from radiotherapy-related changes after SBRT. The imaging changes observed after SBRT may also differ from those observed following conventionally fractionated radiotherapy. Hence, we aim to review the imaging changes that occur within the tumour and adjacent normal liver after SBRT which may help to identify local relapse in clinical practice.

Original languageEnglish
Article numberS11
JournalChinese Clinical Oncology
Volume6
DOIs
Publication statusPublished - 1 Sept 2017

Keywords

  • CT
  • Liver
  • Magnetic resonance imaging (MRI)
  • Stereotactic body radiotherapy (SBRT)

Fingerprint

Dive into the research topics of 'Challenges in imaging assessment following liver stereotactic body radiotherapy: Pitfalls to avoid in clinical practice'. Together they form a unique fingerprint.

Cite this